ORGARAN

injectable antithrombotic medicines; namely, low molecular weight heparinoid, containing a mixture of low and high affinity heparan sulphate, dermatan sulphate and condoiten sulphate and antithrombotic pharmaceutical preparations; namely, low molecular weight heparinoid, containing a mixture of low and high affinity heparan sulphate, dermatan sulphate and condoiten sulphate for human use